We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
05 Mar 2022 - 09 Mar 2022
Virtual Venue

Global Clinical Immunoanalyzers Market to Be Driven by High Incidence of Chronic and Infectious Diseases

By LabMedica International staff writers
Posted on 28 Dec 2021
Print article

The global clinical immunoanalyzers market has been witnessing high demand due to the high prevalence and incidence rates of chronic and infectious diseases, rapid growth in the elderly population, strong economic growth in the emerging markets, decline in oil prices, and health insurance reforms globally. However, low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes have been hampering market growth.

These are the latest findings of Reports and Data (New York City, NY, USA), a market research and consulting company.

Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth of the global clinical immunoanalyzers market. However, rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations could hamper market growth.

Other factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing diseases in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology.

Geographically, North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, the healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus on the developing regions, especially the emerging economies of Asia Pacific.

Related Links:
Reports and Data 

Gold Supplier
Blood Glucose Laboratory Analyzer
Nova Primary
Portable Tube Luminometer
Junior LB 9509
UV/Vis Spectrophotometer
BioDrop DUO+
5-Part Differential Hematology Analyzer
DxH 690T

Print article
IIR Middle East


Molecular Diagnostics

view channel
Image: The ultrarapid genome sequencing pipeline, indicating all processes from sample collection to a diagnosis. Vertically stacked processes are run in parallel (Photo courtesy of Stanford University)

Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting

A genetic diagnosis can guide clinical management and improve prognosis in critically ill patients, and much effort has gone into developing methods that result in rapid, reliable results.... Read more


view channel
Image: My Qualiris QC (Photo courtesy of Stago)

Stago Launches New My Qualiris QC Website for Brand-New User Experience

Stago (Paris, France) has launched its new My Qualiris QC website which provides a brand-new user experience with a 24/7 accessible web-application where the results of a user’s network are only a few clicks away.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.